First-pass extracted concept

ACE2

Candidate: concept label2 source documents6 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

Angiotensin-converting enzyme 2

Evidence Snippets

Web research summary identifies ACE2 as the canonical host entry receptor and cites primary papers establishing ACE2 dependence for SARS-CoV-2 entry.

Evidence 1Source 1DOI PubMedprovenance

Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1review2021Nature Reviews Molecular Cell BiologyDOI PubMed

1 evidence snippet 2 linked claims Claim 1 Claim 2

Source 2review2020Life SciencesDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1mechanistic summarysupports2021Source 1DOI PubMed

ACE2 is presented as the canonical host receptor for SARS-CoV-2 entry in the source-associated evidence scaffold.

Claim 2review scope summarysupports2021Source 1DOI PubMed

This review synthesizes mechanisms of SARS-CoV-2 entry into cells, centering receptor usage, protease-dependent spike activation, and alternative entry routes.

Claim 3mechanistic scopesupports2020Source 2DOI PubMed

The review discusses ACE2 downregulation in SARS-CoV-2 infection as part of the disease mechanism.

Claim 4mechanistic scopesupports2020Source 2DOI PubMed

The review frames ACE2 as having a protective role in the context of SARS-CoV-2 infection.

Claim 5pathophysiology scopesupports2020Source 2DOI PubMed

The review proposes a link between ACE2 downregulation in SARS-CoV-2 infection and macrophage activation syndrome.

Claim 6therapeutic scopesupports2020Source 2DOI PubMed

The review includes therapeutic implications arising from the ACE2 downregulation and macrophage activation syndrome framing in SARS-CoV-2 infection.